Soluble Fas and soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis: a Tunisian case-control study.
Mrabet
D
D
Hajri
R
R
Hamzaoui
K
K
Attia Romdhane
N
N
Zakraoui
L
L
D000368:Aged; D017209:Apoptosis / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D015415:Biomarkers / Q000378:metabolism; D016022:Case-Control Studies; D053222:Fas Ligand Protein / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D020370:Osteoarthritis, Knee / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D013582:Synovial Fluid / Q000378:metabolism*; D013583:Synovial Membrane / Q000378:metabolism / Q000473:pathology; D014416:Tunisia; D019014:fas Receptor / Q000378:metabolism*
D015415:Biomarkers; D053222:Fas Ligand Protein; D019014:fas Receptor